In this case report, an 8-year-old Spitz dog with refractory dermatophytosis showed significant clinical improvement after switching to posaconazole, chosen based on antifungal susceptibility testing, offering a promising treatment option for dogs unresponsive to standard antifungal therapies.
January 2026 in “Preprints.org” In this study, a case of a Spitz dog with refractory dermatophytosis demonstrated marked clinical improvement and complete cure with Posaconazole, highlighting the potential of antifungal susceptibility testing to guide effective treatment in persistent infections unresponsive to standard therapies.
6 citations
,
October 2023 in “JAAD Case Reports” This study describes dissecting cellulitis of the scalp (DCS) as a rare and aggressive form of chronic scalp inflammation presenting with pustules and nodules, commonly affecting males and African Americans, and leading to significant quality of life impacts and psychological distress.
5 citations
,
May 2023 in “Clinical Rheumatology” This case report highlights a 33-year-old female with systemic lupus erythematosus and refractory alopecia who experienced significant hair regrowth after treatment with tofacitinib, maintained even after glucocorticoid tapering over two years.
24 citations
,
March 2022 in “Journal of the American Academy of Dermatology” Adalimumab improved folliculitis decalvans in most patients.
